Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary Biotech Breakthrough: LiveNAI Stock Rockets on Game-Changing Cancer Therapy Interest Intellia's Big Chill: Manufacturing Woes Trigger a Wave of Downgrades